Sarafoglou Kyriakie, Grosse-Redlinger Krista, Boys Christopher J, Charnas Laurence, Otten Noelle, Broock Robyn, Nyhan William L
Department of Pediatrics, University of Minnesota, MMC 8404, 13-124 PWB, 516 Delaware St. SE, Minneapolis, MN 55455, USA.
Arch Neurol. 2010 Jun;67(6):761-4. doi: 10.1001/archneurol.2010.116.
Lesch-Nyhan disease is an inborn error of purine metabolism that results from deficiency of the activity of hypoxanthine phosphoribosyltransferase (HPRT). The heterogeneity of clinical phenotypes seen in HPRT deficiency corresponds to an inverse relationship between HPRT enzyme activity and clinical severity. With rare exception, each mutation produces a stereotypical pattern of clinical disease; onset of neurologic symptoms occurs during infancy and is thought to be nonprogressive.
To document a family in which a single HPRT gene mutation has led to 3 different clinical and enzymatic phenotypes.
Case report. Settings A university-based outpatient metabolic clinic and a biochemical genetics laboratory. Patients Three males (2 infants and their grandfather) from the same family with Lesch-Nyhan variant, including one of the oldest patients with Lesch-Nyhan variant at diagnosis (65 years).
Clinical and biochemical observations.
Sequencing of 5 family members revealed a novel mutation c.550G>T in exon 7 of the HPRT gene. The considerably variable clinical phenotype corresponded with the variable enzymatic activity in the 3 males, with the grandfather being the most severely affected.
The different phenotypes encountered in the enzymatic analysis of cultured fibroblasts from a single mutation in the same family is unprecedented. The significant decrease in the grandfather's HPRT enzymatic activity compared with that of his grandchildren could be a function of the Hayflick Limit Theory of cell senescence.
莱施-奈恩病是一种嘌呤代谢的先天性缺陷疾病,由次黄嘌呤磷酸核糖转移酶(HPRT)活性缺乏所致。HPRT缺乏症中所见临床表型的异质性与HPRT酶活性和临床严重程度呈反比关系。除极少数例外,每种突变都会产生一种典型的临床疾病模式;神经症状在婴儿期出现,且被认为不会进展。
记录一个单一HPRT基因突变导致3种不同临床和酶学表型的家系。
病例报告。地点:一所大学的门诊代谢诊所和一个生化遗传学实验室。患者:来自同一家系的3名男性(2名婴儿及其祖父)患有莱施-奈恩变异型,其中包括诊断时年龄最大的莱施-奈恩变异型患者之一(65岁)。
临床和生化观察结果。
对5名家庭成员进行测序,发现HPRT基因第7外显子有一个新的突变c.550G>T。显著不同的临床表型与3名男性中不同的酶活性相对应,祖父受影响最严重。
同一家系中单一突变在培养成纤维细胞酶分析中出现不同表型的情况前所未见。与他的孙辈相比,祖父的HPRT酶活性显著降低可能是细胞衰老的海弗利克极限理论的作用结果。